Geneix
London
About Geneix
Geneix was founded on the belief that smart data, coupled with smart design, can play a significant role in providing solutions which meet the ever growing need and demand for new solutions which improve patient care, reduce costs and increase efficiency. Geneix's first digital solution, InterAct, is an e-prescribing platform that uses big data to help lower the potential of drug to drug interactions. By using a simple application a healthcare professional can retrieve a patient's electronic medical health records, select a treatment they would like to prescribe and receive an instantaneous warning if the suggested prescription will interact with any current treatments. InterAct not only warns healthcare professionals of any potential interactions at the point of prescription, it also offers alternatives with few or no known interactions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $28.5K
- Funding stage: Seed
- Last round: Seed (Mar 2014)
- Website: geneix.com
- Phone: 44 79 4677 5167
Industries & Categories
Big Data, Biotechnology, Clinical Trials, Health Care, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/geneix-3506356 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.